Edition:
United Kingdom

SAGE Therapeutics Inc (SAGE.OQ)

SAGE.OQ on NASDAQ Stock Exchange Global Market

146.68USD
7:18pm BST
Change (% chg)

$-6.78 (-4.42%)
Prev Close
$153.46
Open
$152.69
Day's High
$154.70
Day's Low
$146.36
Volume
145,098
Avg. Vol
203,121
52-wk High
$195.97
52-wk Low
$59.59

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.00 -1.683
FY 2017 Dec '17 0.00 -1.720
Sep '17 0.00 -1.967
Jun '17 0.00 -1.879
Mar '17 0.00 -1.523
FY 2016 Dec '16 0.00 -1.498
Sep '16 0.00 -1.146
Jun '16 0.00 -1.084
Mar '16 0.00 -0.965
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 11 0.00 0.00 0.00 0.00
Quarter Ending Sep-18 11 0.00 0.00 0.00 13.60
Year Ending Dec-18 13 7.99 103.86 0.00 42.44
Year Ending Dec-19 12 58.00 155.78 12.20 246.09
Earnings (per share)
Quarter Ending Jun-18 12 -1.88 -1.73 -2.06 -1.71
Quarter Ending Sep-18 12 -2.22 -1.90 -2.79 -1.47
Year Ending Dec-18 12 -8.32 -6.18 -10.62 -5.83
Year Ending Dec-19 11 -8.52 -5.24 -12.39 -2.06
LT Growth Rate (%) 1 -15.40 -15.40 -15.40 -2.20
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 82.81 32.74
P/E High - Last 5 Yrs. -- 289.15 45.73
P/E Low - Last 5 Yrs. -- 90.24 24.23
Beta -- 0.91 0.88
Price to Sales (TTM) -- 109.18 5.71
Price to Book (MRQ) 9.22 13.44 5.37
Price to Tangible Book (MRQ) 9.22 13.96 6.94
Price to Cash Flow (TTM) -- 70.39 23.32
% Owned Institutions -- 13.84 2.17

Dividends

  Company industry sector
Dividend Yield -- 0.34 1.50
Dividend Yield - 5 Year Avg -- 0.25 1.51
Dividend 5 Year Growth Rate -- 1.64 5.32
Payout Ratio(TTM) -- 15.83 43.29

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 392.54 7.89
Sales (TTM) vs TTM 1 Yr. Ago -- 77.35 5.68
Sales - 5 Yr. Growth Rate -- 32.11 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago -73.38 24.53 19.38
EPS (TTM) vs TTM 1 Yr. Ago -55.99 -- --
EPS - 5 Yr. Growth Rate -- 39.08 10.78
Capital Spending - 5 Yr. Growth Rate -- 40.34 15.47

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.83 2.19
Current Ratio (MRQ) 9.02 5.26 2.98
LT Debt to Equity (MRQ) 0.00 24.54 12.19
Total Debt to Equity (MRQ) 0.00 26.17 16.46
Interest Coverage (TTM) -- -97.42 32.81

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.81 54.46
Gross Margin - 5 Yr. Avg. -- 51.76 52.22
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -564.12 10.98
Operating Margin (TTM) -- -706.11 4.74
Operating Margin - 5 Yr. Avg. -- -585.15 6.41
Pre-Tax Margin (TTM) -- -681.03 5.58
Pre-Tax Margin - 5 Yr. Avg. -- -588.45 6.83
Net Profit Margin (TTM) -- -682.46 1.88
Net Profit Margin - 5 Yr. Avg. -- -591.46 3.10
Effective Tax Rate (TTM) -- 22.64 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.26 23.95

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 22,312,275 846,855,748
Net Income/Employee (TTM) -1,634,645 2,947,385 99,619,396
Receivable Turnover (TTM) -- 19.92 5.78
Inventory Turnover (TTM) -- 2.37 3.35
Asset Turnover (TTM) 0.00 0.39 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -77.56 -0.70 10.95
Return on Assets - 5 Yr. Avg. -- -0.06 12.32
Return on Investment (TTM) -85.13 2.00 14.38
Return on Investment - 5 Yr. Avg. -- 2.81 16.11
Return on Equity (TTM) -85.28 3.49 16.08
Return on Equity - 5 Yr. Avg. -- 4.33 17.41
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -39.54 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for SAGE Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 345
Total Shares Held: 47,586,368
3 Mo. Net Change: 3,519,676
# New Positions: 65
# Closed Positions: 32
# Increased Positions: 199
# Reduced Positions: 116
# Net Buyers: 83
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.